Science Explorer Back to mapMap
Discussion

VIR Biotechnology (United States)

World rank, all time
#7,614
of 34,923
Rank in United States
#1,581
of 7,310
Research works
152
▲ 68% vs 2018-21
Citations
11k
72.9 per fractional work
Top-10% rate
19.9%
all institutions 10.0%
vs its own fields
1.28×
1.00× is exactly expected
Open access
66%
world 40%
International
38%
world 18%

Which fields of science does VIR Biotechnology (United States) work in?

In 2022-now, 53% of research at VIR Biotechnology (United States) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (8%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 29 fractional works · 53.1% of its workMedicine: 28 fractional works · 51.7% of its workInfectious Diseases: 6 fractional works · 11.6% of its workEpidemiology: 4 fractional works · 7.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.3% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 3.8% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.5% of its workOncology: 2 fractional works · 3.4% of its workPhysiology: 2 fractional works · 3.2% of its workNeurology: 1 fractional works · 2.5% of its workHepatology: 1 fractional works · 2.4% of its workRheumatology: 1 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.1% of its workEmergency Medicine: 1 fractional works · 0.9% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.7% of its workUrology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workHealth Professions: 1 fractional works · 1.0% of its workOccupational Therapy: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.5% of its workEquine: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 16 fractional works · 28.7% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 17.9% of its workMolecular Biology: 7 fractional works · 12.6% of its workGenetics: 1 fractional works · 1.7% of its workCancer Research: 1 fractional works · 1.4% of its workCell Biology: 1 fractional works · 1.2% of its workBiotechnology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 4 fractional works · 7.5% of its workImmunology: 3 fractional works · 6.1% of its workVirology: 1 fractional works · 1.1% of its workParasitology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 2.4% of its workAnimal Science and Zoology: 1 fractional works · 1.0% of its workAgronomy and Crop Science: 0 fractional works · 0.6% of its workPlant Science: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workPhysical Sciences: 8 fractional works · 14.0% of its workComputer Science: 3 fractional works · 5.5% of its workComputational Theory and Mathematics: 1 fractional works · 2.1% of its workComputer Vision and Pattern Recognition: 1 fractional works · 1.2% of its workInformation Systems: 1 fractional works · 1.2% of its workArtificial Intelligence: 0 fractional works · 0.7% of its workSoftware: 0 fractional works · 0.3% of its workEngineering: 2 fractional works · 4.1% of its workBiomedical Engineering: 1 fractional works · 2.0% of its workMedia Technology: 0 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.5% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.3% of its workCivil and Structural Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 1.7% of its workEcology: 0 fractional works · 0.9% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.3% of its workEnvironmental Engineering: 0 fractional works · 0.2% of its workWater Science and Technology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 1 fractional works · 1.0% of its workModeling and Simulation: 0 fractional works · 0.7% of its workStatistics and Probability: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.4% of its workSpectroscopy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 4.2% of its workBusiness, Management and Accounting: 1 fractional works · 1.8% of its workManagement Information Systems: 0 fractional works · 0.6% of its workManagement of Technology and Innovation: 0 fractional works · 0.6% of its workStrategy and Management: 0 fractional works · 0.6% of its workPsychology: 1 fractional works · 1.3% of its workClinical Psychology: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.5% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.2% of its workManagement Science and Operations Research: 0 fractional works · 0.2% of its workALL ITS WORKVIR Biotechnology(United States)54fractional works, 2022-now
Life Sciences29%Physical Sciences14%Health Sciences53%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine2851.7%
    2. Health Professions11.0%
    3. Veterinary00.5%
    1. Biochemistry, Genetics and Molecular Biology1017.9%
    2. Immunology and Microbiology47.5%
    3. Agricultural and Biological Sciences12.4%
    4. Neuroscience00.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Computer Science35.5%
    2. Engineering24.1%
    3. Environmental Science11.7%
    4. Mathematics11.0%
    5. Materials Science00.7%
    6. Chemistry00.4%
    7. Energy00.3%
    8. Physics and Astronomy00.2%
    1. Business, Management and Accounting11.8%
    2. Psychology11.3%
    3. Social Sciences00.5%
    4. Economics, Econometrics and Finance00.3%
    5. Decision Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.50× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.36× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 7.48× its world share, 4 worksImmunology and Micro…Neuroscience: 0.47× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.29× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.26× its world share, 0 worksChemistryComputer Science: 0.71× its world share, 3 worksComputer ScienceEnergy: 0.36× its world share, 0 worksEnergyEngineering: 0.27× its world share, 2 worksEngineeringEnvironmental Science: 0.34× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.19× its world share, 0 worksMaterials ScienceMathematics: 0.87× its world share, 1 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.36× its world share, 0 worksHealth ProfessionsMedicine: 2.69× its world share, 28 worksMedicineVeterinary: 3.76× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.57× its world share, 1 worksBusiness, Management…Decision Sciences: 0.21× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.16× its world share, 0 worksEconomics, Econometr…Psychology: 0.42× its world share, 1 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.5×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Immunology and Microbiology7.48×4 works
  2. Veterinary3.76×0 works
  3. Biochemistry, Genetics and Molecular Biology3.36×10 works
  4. Medicine2.69×28 works
  5. Mathematics0.87×1 works
  6. Computer Science0.71×3 works
  7. Business, Management and Accounting0.57×1 works
  8. Agricultural and Biological Sciences0.50×1 works
  9. Neuroscience0.47×0 works
  10. Psychology0.42×1 works
  11. Energy0.36×0 works
  12. Health Professions0.36×0 works
  13. Environmental Science0.34×1 works
  14. Pharmacology, Toxicology and Pharmaceutics0.29×0 works
  15. Engineering0.27×2 works
  16. Chemistry0.26×0 works
  17. Decision Sciences0.21×0 works
  18. Materials Science0.19×0 works
  19. Economics, Econometrics and Finance0.16×0 works
  20. Physics and Astronomy0.09×0 works
  21. Social Sciences0.04×0 works

Who are the top researchers at VIR Biotechnology (United States)?

Ranked on the quality score, Gyorgy Snell, Florian A. Lempp and Laura E. Rosen lead among researchers whose main affiliation is VIR Biotechnology (United States).

  1. 1 Gyorgy Snell United States · #23,035 worldwide 16k citations · 77 works
  2. 2 Florian A. Lempp United States · #38,025 worldwide 8k citations · 80 works
  3. 3 Laura E. Rosen United States · #68,014 worldwide 10k citations · 46 works
  4. 4 Lisa A. Purcell United States · #68,671 worldwide 7k citations · 75 works
  5. 5 Julia di Iulio United States · #72,650 worldwide 11k citations · 83 works
  6. 6 Terri Wrin United States · #87,287 worldwide 20k citations · 164 works
  7. 7 Christy M. Hebner United States · #227,906 worldwide 4.3k citations · 36 works
  8. 8 Leah B. Soriaga United States · #285,514 worldwide 4.5k citations · 27 works
  9. 9 Maria L. Agostini United States · #300,723 worldwide 6k citations · 30 works
  10. 10 Martin Borch Jensen United States · #339,643 worldwide 2k citations · 76 works
All ranked researchers at VIR Biotechnology (United States)

What are the most cited papers from VIR Biotechnology (United States)?

The most cited paper from VIR Biotechnology (United States) is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody" (2,164) and "Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology" (1,646).

Most cited papers
#PaperReleasedCitations
1 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
2 Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Dora Pinto et al. · Nature Open access 18 May 2020 2,164
3 Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology Luca Piccoli et al. · Cell Open access 16 Sep 2020 1,646
4 Identification of the platelet ADP receptor targeted by antithrombotic drugs Gunther Hollopeter, Hans‐Michael Jantzen, D Vincent et al. · Nature 2001 1,433
5 Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Elisabetta Cameroni et al. · Nature Open access 23 Dec 2021 1,212
All 59 most cited papers, with filters and sorting

Which keywords describe research at VIR Biotechnology (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Pandemic, SARS-CoV-2, Immune Response, ACE2 Receptor, Epidemiology, Vaccine, Immunity and Coronavirus.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 3.5×31 topics
  2. Pandemic6▲ 12×6 topics
  3. SARS-CoV-26▲ 33×3 topics
  4. Immune Response5▲ 17×11 topics
  5. ACE2 Receptor5▲ 42×3 topics
  6. Vaccine5▲ 23×8 topics
  7. Immunity4▲ 19×4 topics
  8. Coronavirus4▲ 33×3 topics
  9. Viral Transmission3▲ 45×3 topics
  10. Inflammation3▲ 2.8×19 topics
  11. Mutation3▲ 32×2 topics
  12. antibody3▲ 57×1 topic
  13. spike protein3▲ 57×1 topic
  14. Monoclonal Antibodies3▲ 57×3 topics
  15. Pathogenesis2▲ 8.9×13 topics
  16. Therapeutic Antibodies2▲ 60×2 topics
  17. Glycosylation2▲ 37×3 topics
  18. Thrombosis2▲ 14×2 topics
  19. Fibrosis2▲ 19×4 topics
  20. Clinical Characteristics2▲ 30×1 topic
  21. Cytokine Storm2▲ 36×1 topic
  22. Pathophysiology2▲ 13×3 topics
  23. Antiviral Therapy2▲ 36×3 topics
  24. Heart Failure2▲ 7.9×6 topics
  25. Antibody Engineering2▲ 57×1 topic
  26. Fc Receptors2▲ 57×1 topic
  27. Insulin Resistance2▲ 7.0×5 topics
  28. Liver Disease2▲ 35×3 topics
  29. Hepatocellular Carcinoma2▲ 14×2 topics
  30. Hypertrophy2▲ 40×2 topics
  31. Innate Immunity2▲ 8.4×4 topics
  32. TGF-ß2▲ 17×2 topics
  33. Immunogenicity1▲ 60×3 topics
  34. Biopharmaceuticals1▲ 45×3 topics
  35. Cancer Immunotherapy1▲ 16×2 topics
  36. Epithelial-Mesenchymal Transition1▲ 25×2 topics
  37. Idiopathic Pulmonary Fibrosis1▲ 49×1 topic
  38. Interstitial Lung Disease1▲ 35×1 topic
  39. Mitochondrial Dysfunction1▲ 8.0×4 topics
  40. Antigen Presentation1▲ 25×2 topics

Which research topics does VIR Biotechnology (United States) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
  5. 5 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  6. 6 Hepatitis B Virus Studies Epidemiology 1 works
  7. 7 Long-Term Effects of COVID-19 Neurology 1 works
  8. 8 Influenza Virus Research Studies Epidemiology 1 works
  9. 9 Immunotherapy and Immune Responses Immunology 1 works
  10. 10 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.8%not open34.2%

World: 40% of research is openly available.

with international co-authors38.3%domestic only61.7%

World: 18% is written across borders.

How has VIR Biotechnology (United States)'s research output changed?

Output in 2022-2025 was 68% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is VIR Biotechnology (United States) as a percentage of every work published that year, 0.00028% in 2024.

still counting0.00020%0.00040%0.00060%VIR Biotechnology (United States)0.00024% in 202519801990200020102020

Fractional works of VIR Biotechnology (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Francisco

All research institutions in San Francisco

Share VIR Biotechnology (United States)'s ranking

VIR Biotechnology (United States) on Science Explorer

A card with VIR Biotechnology (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about VIR Biotechnology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.